IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT

IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT

Mostrar otras versiones (1)

Case report: We report a 28-year-old Asian male patient, known for ITP and in partial remission for eighteen months, who presented to emergency department with ITP relapse (platelets count of 1 × 10^3 /uL), four days after receiving the second dose of Pfizer SARS-CoV-2 vaccine, which required treatm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Hana Qasim
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Diseases of the blood and blood-forming organs
RC633-647.5
Acceso en línea:https://doaj.org/article/637f628e5acb4ebcab540ded3005299d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:637f628e5acb4ebcab540ded3005299d
record_format dspace
spelling oai:doaj.org-article:637f628e5acb4ebcab540ded3005299d2021-11-10T04:36:36ZIMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT2531-137910.1016/j.htct.2021.10.1046https://doaj.org/article/637f628e5acb4ebcab540ded3005299d2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2531137921011937https://doaj.org/toc/2531-1379Case report: We report a 28-year-old Asian male patient, known for ITP and in partial remission for eighteen months, who presented to emergency department with ITP relapse (platelets count of 1 × 10^3 /uL), four days after receiving the second dose of Pfizer SARS-CoV-2 vaccine, which required treatment with intravenous immunoglobulins and dexamethasone, we discuss as well the likely underlying pathophysiology and the suggested approach in patients known for ITP who are willing to receive mRNA COVID vaccines.Hana QasimElsevierarticleDiseases of the blood and blood-forming organsRC633-647.5ENHematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S46- (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the blood and blood-forming organs
RC633-647.5
spellingShingle Diseases of the blood and blood-forming organs
RC633-647.5
Hana Qasim
IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT
description Case report: We report a 28-year-old Asian male patient, known for ITP and in partial remission for eighteen months, who presented to emergency department with ITP relapse (platelets count of 1 × 10^3 /uL), four days after receiving the second dose of Pfizer SARS-CoV-2 vaccine, which required treatment with intravenous immunoglobulins and dexamethasone, we discuss as well the likely underlying pathophysiology and the suggested approach in patients known for ITP who are willing to receive mRNA COVID vaccines.
format article
author Hana Qasim
author_facet Hana Qasim
author_sort Hana Qasim
title IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT
title_short IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT
title_full IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT
title_fullStr IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT
title_full_unstemmed IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT
title_sort immune thrombocytopenia relapse post covid-19 vaccine in young male patient
publisher Elsevier
publishDate 2021
url https://doaj.org/article/637f628e5acb4ebcab540ded3005299d
work_keys_str_mv AT hanaqasim immunethrombocytopeniarelapsepostcovid19vaccineinyoungmalepatient
_version_ 1718440562815664128

Ejemplares similares